Preview: Bio-Path Holdings's Earnings
Portfolio Pulse from Benzinga Insights
Bio-Path Holdings (NASDAQ:BPTH) is expected to release its quarterly earnings report on November 15, 2023, with an estimated EPS of $-0.34. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, BPTH's stock price has been sensitive to earnings performance and guidance. Last quarter, the company missed EPS estimates, resulting in a 7.92% increase in share price the following day. Over the past year, BPTH shares have declined by 63.84%.
November 14, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bio-Path Holdings is anticipated to report quarterly earnings with an EPS estimate of $-0.34. Investors will focus on earnings results and forward guidance, which historically have influenced the stock's price movement.
The short-term impact on BPTH's stock price will likely depend on whether the company beats or misses the EPS estimate and the nature of the guidance provided. Historical data shows that the stock is volatile post-earnings, but with a recent downtrend, investor sentiment may already be low.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100